rs149911553
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004817.4(TJP2):āc.1877C>Gā(p.Thr626Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,614,170 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T626T) has been classified as Likely benign.
Frequency
Consequence
NM_004817.4 missense
Scores
Clinical Significance
Conservation
Publications
- cholestasis, progressive familial intrahepatic, 4Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
- familial hypercholanemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypercholanemia, familial 1Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TJP2 | ENST00000377245.9 | c.1877C>G | p.Thr626Ser | missense_variant | Exon 13 of 23 | 1 | NM_004817.4 | ENSP00000366453.4 | ||
| ENSG00000285130 | ENST00000642889.1 | c.2264C>G | p.Thr755Ser | missense_variant | Exon 15 of 25 | ENSP00000493780.1 |
Frequencies
GnomAD3 genomes AF: 0.00104 AC: 158AN: 152160Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00101 AC: 253AN: 251442 AF XY: 0.000920 show subpopulations
GnomAD4 exome AF: 0.00138 AC: 2023AN: 1461892Hom.: 2 Cov.: 32 AF XY: 0.00135 AC XY: 982AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00104 AC: 158AN: 152278Hom.: 1 Cov.: 32 AF XY: 0.000900 AC XY: 67AN XY: 74450 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
This variant is associated with the following publications: (PMID: 32089630, 28924228) -
- -
- -
not specified Benign:2
Thr603Ser in exon 14 of TJP2: This variant is not expected to have clinical sign ificance because it has been identified in 0.2% (14/8600) of European American c hromosomes chromosomes from a broad population by the NHLBI Exome Sequencing Pro ject (http://evs.gs.washington.edu/EVS/; dbSNP rs149911553) and this amino acid position is not evolutionarily conserved in mammals. -
- -
TJP2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at